Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer
2021 · Molecular Therapy — Oncolytics · 102 citations
https://doi.org/10.1016/j.omto.2021.01.002
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
901
Citations
9
h-index
9
i10-index
Junli Zhuang is an academic researcher from Australian Regenerative Medicine Institute. The author has contributed to research in topics: Genomics and Phylogenetic Studies & CAR-T cell therapy research & CRISPR and Genetic Engineering. The author has an h-index of 9, co-authored 18 publications.
ORCID: 0000-0002-1251-1639https://doi.org/10.1016/j.omto.2021.01.002
https://doi.org/10.1038/s41598-023-33287-9
https://doi.org/10.1016/j.jad.2024.01.128
Click to start Chat